Skip to main content
. 2014 Nov;10(4):309–314. doi: 10.2174/1573403X10666140513103709

Fig. (3).

Fig. (3)

Termination of recent onset AF following intravenous infusion of vernakalant compared with placebo (ACT I, II and III) or amiodarone (AVRO). The median time to termination was between 8 and14 minutes. 75-80% converted after the first dose.